Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have glaucoma-related damage to the optic nerve (the nerve connecting the eye to the brain) in both eyes
- People aged between 40 and 90 years old
- People whose vision, even with glasses or contact lenses, meets a certain minimum level of clarity (confirm with trial site for exact details)
- People whose prescription falls within a moderate range — not too short-sighted or long-sighted (between -6 and +6 on the lens scale)
- People whose astigmatism (irregular curvature of the eye) falls within a moderate range (between -2 and +2 on the lens scale)
Who may not be able to join:
- People who have had any eye surgery, except for uncomplicated cataract surgery and/or glaucoma surgery in both eyes, if that surgery was done within 6 months before joining the trial
- People who have any other eye condition, aside from glaucoma, that could affect their field of vision (the full area a person can see without moving their eyes)
- People taking any medication that could interfere with vision field testing or cause vision field loss
- People who are unable to produce reliable results during vision field tests
- People whose glaucoma is at an advanced stage where, in the treating doctor's judgment, a standard type of vision field test (called a 24-2 grid) would not be appropriate for monitoring their condition
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Luca M. Rossetti, Prof., Clinica oculistica Ospedale San Paolo
Phone: +39 049 501 8399
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Equivalence between Compass and HFA in terms of estimation of the global progression rate (MD progression slope).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.